Maria Cristina Díaz de Heredia Rubio I am a pediatrician specialized in pediatric hematology and oncology and in hematopoietic stem cell transplantation. My clinical and research activity focuses on blood disorders, leukemias, and other non-oncological hematological diseases, as well as on hematopoietic stem cell transplantation in children. Since 2005, I am the Head of the Pediatric Hematology Section and I lead the Hematopoietic Stem Cell Transplantation and Advanced Therapies Program within the Department of Pediatric Oncology and Hematology. I am committed to bringing the most innovative treatments to our patients. At the national level, I lead the pediatric group of the Spanish Group for Hematopoietic Transplantation (GETH) and the hematopoietic stem cell transplantation group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP), with the aim of improving the clinical outcomes of this procedure in children and adolescents. I am an active member of the board of the European pediatric hematopoietic stem cell transplantation group of the European Society for Blood and Marrow Transplantation (EBMT), and I actively participate in the SEHOP bone marrow failure working group. My commitment and dedication to hematopoietic stem cell transplantation and bone marrow failure syndromes have made me a national reference in these fields. Institutions of which they are part Predoctoral researcher Childhood Cancer and Blood Disorders Vall Hebron Institut de Recerca Head of Section Paediatric Oncology and Haematology Children's Hospital and Woman's Hospital Email Maria Cristina Díaz de Heredia Rubio Email Institutions of which they are part Predoctoral researcher Childhood Cancer and Blood Disorders Vall Hebron Institut de Recerca Head of Section Paediatric Oncology and Haematology Children's Hospital and Woman's Hospital I am a pediatrician specialized in pediatric hematology and oncology and in hematopoietic stem cell transplantation. My clinical and research activity focuses on blood disorders, leukemias, and other non-oncological hematological diseases, as well as on hematopoietic stem cell transplantation in children. Since 2005, I am the Head of the Pediatric Hematology Section and I lead the Hematopoietic Stem Cell Transplantation and Advanced Therapies Program within the Department of Pediatric Oncology and Hematology. I am committed to bringing the most innovative treatments to our patients. At the national level, I lead the pediatric group of the Spanish Group for Hematopoietic Transplantation (GETH) and the hematopoietic stem cell transplantation group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP), with the aim of improving the clinical outcomes of this procedure in children and adolescents. I am an active member of the board of the European pediatric hematopoietic stem cell transplantation group of the European Society for Blood and Marrow Transplantation (EBMT), and I actively participate in the SEHOP bone marrow failure working group. My commitment and dedication to hematopoietic stem cell transplantation and bone marrow failure syndromes have made me a national reference in these fields.
In terms of research, I am a member of the “Childhood Cancer and Blood Disorders” group at the Vall d’Hebron Research Institute (VHIR) and I lead the Hematopoietic Stem Cell Transplantation and Advanced Therapies Program within this group. I am the national coordinator of the international clinical trial ALL-SCT FORUM, with the objective to identify the optimal transplantation strategy in children and adolescents with acute lymphoblastic leukemia. In the field of advanced cellular therapies, I work on several innovative projects in gene therapy for congenital diseases, as well as on the use of mesenchymal cells and antigen-specific cytotoxic lymphocytes for the treatment of certain post-transplant complications.
Projects Red Temática de Investigación Cooperativa en Cáncer - RTICC IP: Josep Sánchez de Toledo Codina Collaborators: Soledad Gallego Melcón, Luís Gros Subias, Pablo Velasco Puyó, Aroa Soriano Fernández, Maria Cristina Díaz de Heredia Rubio, Miguel Segura Ginard, Constantino Sábado Álvarez, Anna Llort Sales, Laura Alonso Garcia, Josep Roma Castanyer Funding agency: Instituto de Salud Carlos III Funding: 186750 Reference: RD12/0036/0016 Duration: 01/01/2013 - 30/06/2017 Ensayo clínico Fase I/II para evaluar la seguridad y eficacia de la movilización y colecta de células CD34+ tras tratamiento con plerixafor y filgrastim en pacientes con Anemia de Fanconi para su posterior uso en ensayos de terapia génica IP: Maria Cristina Díaz de Heredia Rubio Collaborators: Josep Sánchez de Toledo Codina, Raquel Hladun Alvaro Funding agency: Ministerio Sanidad Funding: 437580 Reference: EC11-559 Duration: 01/01/2012 - 30/06/2018 Estudio de la inmunidad mediada por células en el proceso diagnóstico de los pacientes pediátricos con sospecha de InmunoDeficiencia Combinada (IDC) IP: Mónica Martínez Gallo Collaborators: Aina Aguiló Cucurull, Maria Cristina Díaz de Heredia Rubio, Andrea Martín Nalda Funding agency: Instituto de Salud Carlos III Funding: 104170.11 Reference: PI11/01086 Duration: 01/01/2012 - 30/04/2015 Generación y diferenciación de células madre pluripotentes inducidas (IPS) de pacientes con enfermedades genéticas del sistema inmuno-hematopoyético IP: Josep Sánchez de Toledo Codina Collaborators: Soledad Gallego Melcón, Ramon Gimeno Martinez, Lluis Martorell Cedres, Maria Cristina Díaz de Heredia Rubio, Sergio López Estévez, Silvia Casacuberta Serra, Josep Roma Castanyer Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 302540 Reference: PLE2009-0100 Duration: 10/12/2009 - 31/10/2013 Pagination First page « Previous page ‹ Page 1 Page 2 Current page 3 Page 4 Next page › Last page »
